Picture of Prometheus Biosciences logo

RXDX — Prometheus Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge Cap

Brief: Prometheus Biosciences Says Board Has Appointed Mark Mckenna To Succeed Tadataka Yamada As Chairman

Aug 23 (Reuters) - Prometheus Biosciences Inc  RXDX.O :
    * PROMETHEUS BIOSCIENCES - BOARD HAS APPOINTED MARK C.
MCKENNA TO
SUCCEED TADATAKA YAMADA AS CHAIRMAN
    * PROMETHEUS BIOSCIENCES - BOARD HAS DETERMINED TO APPOINT
JOSEPH
C. PAPA TO SERVE AS LEAD INDEPENDENT DIRECTOR
    * PROMETHEUS BIOSCIENCES - BOARD REDUCED ITS SIZE FROM 9 TO
8
DIRECTORS

Source text for Eikon: [https://bit.ly/3gohtjS]
Further company coverage:  RXDX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Prometheus Biosciences

See all news